97596410 - MOPED

Information

  • Trademark
  • 97596410
  • Serial Number
    97596410
  • Filing Date
    September 19, 2022
    2 years ago
  • Transaction Date
    January 24, 2025
    a month ago
  • Status Date
    August 12, 2024
    7 months ago
  • Published for Opposition Date
    December 19, 2023
    a year ago
  • Location Date
    February 13, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    PORTARO, ALEXANDRA
  • Attorney Docket Number
    ONCO 2208483
    Attorney Name
    Joyce M. Ferraro
    Law Office Assigned Location Code
    N80
  • Owners
Mark Drawing Code
4
Mark Identification
MOPED
Case File Statements
  • GS0091: Downloadable computer software for drug discovery, screenings, and providing pharmaceuticals; downloadable computer software for use to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry, clinical trial management and patient engagement
  • GS0421: Drug discovery services; DNA and protein screening for scientific research purposes; Platform as a service (PAAS) featuring computer software platforms for drug discovery, screenings, and providing pharmaceuticals; Scientific and technological services and research and design, namely, research and design in the field of drug discovery and DNA and protein screening; Scientific research and development in the field of analysis of technical data by computers; pharmaceutical drug discovery services; research and development in the pharmaceutical and biotechnology fields; drug discovery services and research and development in the pharmaceutical drug use field; design and development of pharmaceutical preparations and medicines; scientific research and development in the field of drug discovery; scientific research and development in the nature of conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific research and development in the nature of scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; scientific research and development in the nature of bioinformatics services for using the combination of biology, computer science, information engineering, mathematics and statistics to analyze and interpret biological data; scientific research and development in the nature of computer assisted molecule design; scientific research and development in the nature of identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer aided diagnostic and DNA and protein screening services for scientific research purposes; scientific research and development in the nature of contract research services in support of scientific research and development of pharmaceutical preparations; Software as a service (SaaS) services featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; Software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement
Case File Event Statements
  • 9/22/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/4/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/29/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/7/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/7/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/7/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/5/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/5/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/5/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/14/2023 - a year ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/14/2023 - a year ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/14/2023 - a year ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/14/2023 - a year ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/14/2023 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/29/2023 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/19/2023 - a year ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/19/2023 - a year ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/13/2024 - a year ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/12/2024 - 7 months ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/12/2024 - 7 months ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/12/2024 - 7 months ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/23/2025 - a month ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/12/2024 - 7 months ago
    20 - SOU EXTENSION 1 FILED Type: EXT1